SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.16 Cr | ₹-6.08 Cr | ₹7.28 Cr | ₹1.20 Cr | ₹-5.47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹2.16 Cr |
| Mar2025 | ₹-6.08 Cr |
| Mar2024 | ₹7.28 Cr |
| Mar2020 | ₹1.20 Cr |
| Mar2019 | ₹-5.47 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.16 Cr | Positive | |
| Mar2025 | ₹-6.08 Cr | Negative | |
| Mar2024 | ₹7.28 Cr | 505.66 | |
| Mar2020 | ₹1.20 Cr | Positive | |
| Mar2019 | ₹-5.47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹662.1 Cr | 3.1% | -16.8% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 3.1% |
-16.8% |
-11.8% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses